Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types
- PMID: 30174490
- PMCID: PMC6082763
- DOI: 10.3348/kjr.2018.19.5.1000
Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types
Abstract
Objective: To evaluate the ultrasonography (US) features and clinical characteristics of columnar cell variant of papillary thyroid carcinoma (CCV-PTC) that can predict disease progression.
Materials and methods: Six cases of CCV-PTC were identified via surgical pathology analysis at our institution from 1994 to 2016. The histological, architectural, and cytological features met the diagnostic criteria of CCV-PTC. We reviewed the US features and clinicopathological findings in the six cases.
Results: An indolent clinical course was observed in four young female patients aged 27-34 years (median: 32 years), while two older patients aged 55 years or 70 years had an aggressive clinical course. All patients underwent total thyroidectomy and radioiodine therapy. The indolent group included patients with T1 and nodal metastasis, where the disease was not observed during the follow-up period (range: 8-17 years). On the other hand, a larger tumor size (1.8 cm and 6.0 cm), gross extrathyroidal extension to the muscle and lymph node, and distant metastasis were observed in the aggressive group. In one male patient, recurrence occurred immediately after operation, and this patient died 4 years after the diagnosis of thyroid cancer. Based on US, the individuals from the indolent group had a smooth margin, except for one. Both cases in the aggressive group had a microlobulated margin.
Conclusion: Favorable prognosis in CCV-PTC is observed in young patients with T1 staging and demonstrates a smooth margin at US. These US findings might help exclude the same treatment as the aggressive type in the indolent type of CCV-PTC.
Keywords: Histology; Papillary thyroid carcinoma; Prognosis; Ultrasonography.
Figures


Similar articles
-
Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.Cancer Cytopathol. 2017 Jun;125(6):389-397. doi: 10.1002/cncy.21860. Epub 2017 Apr 3. Cancer Cytopathol. 2017. PMID: 28374549 Review.
-
Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.J Clin Endocrinol Metab. 2013 Apr;98(4):1476-82. doi: 10.1210/jc.2012-4072. Epub 2013 Mar 5. J Clin Endocrinol Metab. 2013. PMID: 23463652
-
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience.Clin Chem Lab Med. 2016 Sep 1;54(9):1531-9. doi: 10.1515/cclm-2015-0218. Clin Chem Lab Med. 2016. PMID: 26863344
-
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.Clin Chem Lab Med. 2011 Feb;49(2):325-9. doi: 10.1515/CCLM.2011.031. Epub 2010 Dec 23. Clin Chem Lab Med. 2011. PMID: 21175381
-
[BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].Acta Med Port. 2011 Dec;24 Suppl 4:855-68. Epub 2011 Dec 31. Acta Med Port. 2011. PMID: 22863493 Review. Portuguese.
Cited by
-
Aggressive Types of Malignant Thyroid Neoplasms.J Clin Med. 2024 Oct 14;13(20):6119. doi: 10.3390/jcm13206119. J Clin Med. 2024. PMID: 39458070 Free PMC article. Review.
-
Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Papillary Thyroid Carcinoma Variants.Cancer Rep (Hoboken). 2024 Dec;7(12):e70071. doi: 10.1002/cnr2.70071. Cancer Rep (Hoboken). 2024. PMID: 39614618 Free PMC article.
-
Demographic and Prognostic Factors of the Columnar Cell Variant of Papillary Thyroid Carcinoma: A National Cancer Database Study.Cureus. 2024 Aug 15;16(8):e66913. doi: 10.7759/cureus.66913. eCollection 2024 Aug. Cureus. 2024. PMID: 39280385 Free PMC article.
-
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4. Endocrinol Metab (Seoul). 2022. PMID: 36193717 Free PMC article. Review.
-
The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline.Endocrinol Metab (Seoul). 2025 Jun;40(3):357-384. doi: 10.3803/EnM.2025.2465. Epub 2025 Jun 24. Endocrinol Metab (Seoul). 2025. PMID: 40598904 Free PMC article. Review.
References
-
- Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns] Cancer. 1998;83:2638–2648. - PubMed
-
- Lee JH, Shin JH, Lee HW, Oh YL, Hahn SY, Ko EY. Sonographic and cytopathologic correlation of papillary thyroid carcinoma variants. J Ultrasound Med. 2015;34:1–15. - PubMed
-
- Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol. 2004;86:44–54. - PubMed
-
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous